US Stock MarketDetailed Quotes
DGX Quest Diagnostics
- 160.440
- +3.600+2.30%
Close Nov 15 16:00 ET
- 160.440
- 0.0000.00%
Post 20:01 ET
17.91BMarket Cap21.56P/E (TTM)
162.130High156.320Low2.73MVolume156.750Open156.840Pre Close437.68MTurnover2.46%Turnover Ratio21.42P/E (Static)111.62MShares162.59052wk High2.63P/B17.76BFloat Cap121.08452wk Low2.96Dividend TTM110.68MShs Float163.085Historical High1.84%Div YieldTTM3.70%Amplitude2.583Historical Low160.564Avg Price1Lot Size
About Quest Diagnostics Company
Quest Diagnostics, Inc. engages in the provision of diagnostic testing, information and services. It operates through the Diagnostic Information Services (DIS) and All Other segments. The DIS segment offers diagnostic information services to patients, clinicians, hospitals, health plans, and employers. The All Other segment consists of risk assessment services, healthcare information technology, diagnostic products, and clinical trials testing businesses. The company was founded in 1967 and is headquartered in Secaucus, NJ.
Company Profile
SymbolDGX
Company NameQuest Diagnostics
Listing DateDec 17, 1996
Founded1967
CEOMr. James E. Davis
MarketNYSE
Employees48000
Fiscal Year Ends12-31
Address500 Plaza Drive
CitySecaucus
ProvinceNew Jersey
CountryUnited States of America
Zip Code07940
Phone1-973-520-2700
Company Executives
- Name
- Position
- Salary
- James E. Davis
- Chairman of the Board, President and Chief Executive Officer
- 12.67M
- Michael J. Deppe
- Senior Vice President, Corporate Controller and Chief Accounting Officer
- --
- Sam A. Samad
- Executive Vice President and Chief Financial Officer
- 3.98M
- Mark Delaney
- Senior Vice President and Chief Commercial Officer
- --
- Karthik Kuppusamy
- Senior Vice President, Clinical Solutions
- 2.02M
- Patrick Plewman
- Senior Vice President, Diagnostic Services
- --
- Catherine T. Doherty
- Senior Vice President, Regional Businesses
- 3.16M
- Michael E. Prevoznik
- Senior Vice President and General Counsel
- 2.25M
- Mark A. Gardner
- Senior Vice President, Molecular Genomics and Oncology
- --
- Robert B. Carter
- Independent Director
- --
- Timothy M. Ring
- Lead Independent Director
- 345.94K
- Denise M. Morrison
- Independent Director
- 312.33K
- Vicky B. Gregg
- Independent Director
- 315.73K
- Tracey C. Doi
- Independent Director
- 300.44K
- Gary M. Pfeiffer
- Independent Director
- 342.12K
- Wright L. Lassiter, III
- Independent Director
- 300.44K
- Timothy L. Main
- Independent Director
- 315.44K
- Dr. Luis A. Diaz, Jr,M.D.
- Independent Director
- 280.41K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
